Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update

M Omata, AL Cheng, N Kokudo, M Kudo, JM Lee… - Hepatology …, 2017 - Springer
There is great geographical variation in the distribution of hepatocellular carcinoma (HCC),
with the majority of all cases worldwide found in the Asia–Pacific region, where HCC is one …

[HTML][HTML] 2018 Korean Liver Cancer Association–National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma

Korean Liver Cancer Association - Korean Journal of Radiology, 2019 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

[HTML][HTML] Role of transarterial chemoembolization in the treatment of hepatocellular carcinoma

BY Zhong, ZC Jin, JJ Chen, HD Zhu… - Journal of Clinical and …, 2023 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. According
to the Barcelona Clinic Liver Cancer (BCLC) staging system, transarterial …

Clinical feasibility and efficacy of stereotactic body radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of observational studies

CH Rim, HJ Kim, J Seong - Radiotherapy and Oncology, 2019 - Elsevier
Background and purpose Stereotactic body radiotherapy (SBRT) is an emerging ablative
modality for hepatocellular carcinoma (HCC). This study aimed to synthesize available …

[HTML][HTML] Transcatheter embolization therapy in liver cancer: an update of clinical evidences

YXJ Wáng, T De Baere, JM Idée… - Chinese Journal of …, 2015 - ncbi.nlm.nih.gov
Transarterial chemoembolization (TACE) is a form of intra-arterial catheter-based
chemotherapy that selectively delivers high doses of cytotoxic drug to the tumor bed …

[HTML][HTML] 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Korean Liver Cancer Association - Korean Journal of Radiology, 2022 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

Percutaneous ablation for hepatocellular carcinoma: comparison of various ablation techniques and surgery

S Shiina, K Sato, R Tateishi, M Shimizu… - Canadian Journal of …, 2018 - Wiley Online Library
Image‐guided percutaneous ablation is considered best in the treatment of early‐stage
hepatocellular carcinoma (HCC). Ablation is potentially curative, minimally invasive, and …

2018 Korean Liver Cancer Association-National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma

JW Park, JS Lee, KS Suh, JW Chung, J Seong… - Gut and …, 2019 - scholarworks.bwise.kr
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

Propensity score matching: a conceptual review for radiology researchers

S Baek, SH Park, E Won, YR Park… - Korean journal of …, 2015 - synapse.koreamed.org
The propensity score is defined as the probability of each individual study subject being
assigned to a group of interest for comparison purposes. Propensity score adjustment is a …

Microwave ablation in primary and secondary liver tumours: technical and clinical approaches

MF Meloni, J Chiang, PF Laeseke… - International journal …, 2017 - Taylor & Francis
Thermal ablation is increasingly being utilised in the treatment of primary and metastatic
liver tumours, both as curative therapy and as a bridge to transplantation. Recent advances …